PubRank

Masatomo Takahashi

Author PubWeight™ 20.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. Blood 2010 1.93
2 A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. Blood 2007 1.74
3 A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study. Blood 2010 1.57
4 Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia. Cancer Sci 2012 1.48
5 Role of serum high mobility group box 1 in hematological malignancies complicated with systemic inflammatory response syndrome and effect of recombinant thrombomodulin. Leuk Lymphoma 2013 1.45
6 Flk1+ cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID mice. Exp Hematol 2002 0.95
7 A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study. Cancer 2005 0.94
8 Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group. Int J Hematol 2011 0.87
9 Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study. Int J Hematol 2004 0.84
10 Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome. Ann Hematol 2014 0.84
11 Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group. Int J Hematol 2009 0.82
12 Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study. Int J Hematol 2010 0.81
13 CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Leuk Res 2013 0.81
14 Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts. Cancer Sci 2014 0.80
15 Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study. Int J Hematol 2010 0.79
16 Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation. Int J Clin Pharmacol Ther 2012 0.79
17 Spontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3). Leuk Lymphoma 2015 0.78
18 The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies. Cancer 2013 0.78
19 Pharmacokinetics of cyclosporine a conversion from twice-daily infusion to oral administration in allogeneic hematopoietic stem cell transplantation. Am J Ther 2014 0.78
20 Treatment with valproic acid for myelofibrosis with myeloid metaplasia. Ann Hematol 2005 0.76
21 Photophysical properties of substituted homoleptic and heteroleptic phenylimidazolinato Ir(III) complexes as a blue phosphorescent material. Inorg Chem 2013 0.75
22 Acute myeloid leukaemia with cup-like nuclei associated with t(9;22)(q34;q11.2). Br J Haematol 2013 0.75
23 Recombinant thrombomodulin improved Stevens-Johnson syndrome with high serum high-mobility group-B1 DNA-binding protein induced by lenalidomide administered to treat multiple myeloma. Thromb Res 2013 0.75
24 Diffuse large B-cell lymphoma with mass lesions of skull vault and ileocecum. J Clin Exp Hematop 2013 0.75
25 PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32). Int J Hematol 2015 0.75
26 [Efficacy of itraconazole injections for treatment of febrile neutropenia]. Jpn J Antibiot 2008 0.75
27 Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF. Int J Hematol 2008 0.75
28 [Isolated granulocytic sarcoma in the breast]. Rinsho Ketsueki 2003 0.75